Please download the dossier by clicking on the dossier button x
×

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

  • US 10,695,377 B2
  • Filed: 11/22/2019
  • Issued: 06/30/2020
  • Est. Priority Date: 02/21/2018
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a patient who has cancer, comprising administering to said patient a population of activated T cells that kill cancer cells that present a peptide consisting of the amino acid sequence of SEQ ID NO:

  • 4,wherein said cancer is selected from AML (acute myeloid leukemia), BRCA (breast cancer), CCC (cholangiocellular carcinoma), CLL (chronic lymphocytic leukemia), GBM (glioblastoma), HCC (hepatocellular carcinoma), MEL (melanoma), NHL (non-Hodgkin lymphoma), NSCLC (non-small cell lung cancer), OSCAR (esophageal cancer), RCC (renal cell carcinoma), SCLC (small cell lung cancer), and UBC (urinary bladder carcinoma).

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×